Search Results 541-550 of 17346 for soluble fibers
The purpose of this study is to determine a dose of LY2784544 that may be safely administered to participants with myeloproliferative neoplasms. Participation ...
The purpose of this study is to determine if fluticasone furoate/vilanterol improves survival in patients with chronic obstructive pulmonary disease with a ...
The purpose of this study is to optimize methods in order to analyze immune cell profile in tissue and urine of bladder cancer patients. Participation ...
About this study. The purpose of this study is to assess patient reported outcomes related to medication side effects > 1 year after kidney transplant and ...
The purpose of this study is to determine the 4-month Progression-Free Survival (PFS), with demonstrated increase in tumor doubling time, of eligible subjects ...
Yi Lin, M.D., Ph.D. · Hematologist · Oncologist.
There is a need for new treatments for myelofibrosis (MF) patients based on laboratory insight into disease pathogenesis. We will use primary patient samples to ...
The purpose of this study is to evaluate the outcomes of patients who received an Allograft-Prosthesis Composite for Revision of Catastrophic Failure of Ulnar ...
About this study. This a Phase 1 study designed to determine the maximum tolerated dose (MTD) and toxicity of attenuated Measles virus (MV-NIS) combined ...
200 HEU children previously exposed in utero to DTG/TDF/XTC and their mothers;; 160 HUU children and their mothers. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!